Sorrento Therapeutics, Inc. - stock earnings
Stock symbol SRNE is outdated, potentially delisted? Maybe it is available on other exchange?
SRNE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -89.6 million USD | 17.4 million USD |
| 2022Q2 | -218.8 million USD | 11.5 million USD |
| 2022Q1 | -40.8 million USD | 18.4 million USD |
| 2021Q4 | -144.4 million USD | 13.1 million USD |
| 2021Q3 | -119.8 million USD | 12.1 million USD |
| 2021Q2 | -166.6 million USD | 13.5 million USD |
| 2021Q1 | 2.5 million USD | 14.3 million USD |
| 2020Q4 | -71.5 million USD | 11.5 million USD |
| 2020Q3 | -84.0 million USD | 11.8 million USD |
| 2020Q2 | -77.7 million USD | 9.0 million USD |
SRNE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -428.3 million USD | 52.9 million USD |
| 2020 | -298.5 million USD | 40.0 million USD |
| 2019 | -292.1 million USD | 31.4 million USD |
| 2018 | -203.5 million USD | 21.2 million USD |
| 2017 | 9.1 million USD | 151.9 million USD |
SRNE
Price: $0.31
52 week price:
Earnings Per Share: -0.68 USD
P/E Ratio: -4.43
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 9.3 million
Ebitda: 98.2 millionMarket Capitalization: 168.4 million